Journal of Experimental & Clinical Cancer Research (Dec 2020)
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
Abstract
An amendment to this paper has been published and can be accessed via the original article.